ALHC Relative Valuation
ALHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ALHC is overvalued; if below, it's undervalued.
Historical Valuation
Alignment Healthcare Inc (ALHC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.64 is considered Fairly compared with the five-year average of -90.52. The fair price of Alignment Healthcare Inc (ALHC) is between 6.13 to 37.83 according to relative valuation methord.
Relative Value
Fair Zone
6.13-37.83
Current Price：12.41
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
22.69
P/B
Median3y
12.71
Median5y
11.86
0.73
FCF Yield
Median3y
-4.05
Median5y
-3.67
Competitors Valuation Multiple
The average P/S ratio for ALHC's competitors is 0.37, providing a benchmark for relative valuation. Alignment Healthcare Inc Corp (ALHC) exhibits a P/S ratio of 0.64, which is 74.26% above the industry average. Given its robust revenue growth of 47.46%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Alignment Healthcare Inc (ALHC) currently overvalued or undervalued?
What is Alignment Healthcare Inc (ALHC) fair value?
How does ALHC's valuation metrics compare to the industry average?
What is the current P/B ratio for Alignment Healthcare Inc (ALHC) as of Jul 20 2025?
What is the current FCF Yield for Alignment Healthcare Inc (ALHC) as of Jul 20 2025?
What is the current Forward P/E ratio for Alignment Healthcare Inc (ALHC) as of Jul 20 2025?